Anti-Canine CD20/CD20 Reference Antibody
- Cat. No.：RB9TCY257026
- Price：Negotiable
- Clicks：432
Product Detail
Product Parameters
| Form | Liquid |
|---|---|
| Host Species | Canis |
| Clonality | Monoclonal |
| Isotype | IgG2, lambda |
| Purity | >95% as determined by SDS-PAGE. |
| Purification | Protein A/G purified from cell culture supernatant. |
| Endotoxin Level | < 10 EU/mg |
| Applications | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| Species Reactivity | canine |
| Storage Buffer | 0.01 M PBS pH 7.4 |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -117°C long term. |
| Product Usage Information | ELISA: 1:2000-1:20000 |
| Accession Number | Q3C2E2 |
| Background | B-lymphocyte antigen CD20 (MS4A1) is a ~33 kDa protein. B-lymphocyte-specific membrane protein that plays a role in the regulation of cellular calcium influx necessary for the development, differentiation, and activation of B-lymphocytes. Functions as a store-operated calcium (SOC) channel component promoting calcium influx after activation by the B-cell receptor/BCR. CD20 is the therapeutic target of rituximab (MabThera) and obinutuzumab (Gazyva). |
| Note | For research use only. |
Related Products: